A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis
Clinical trial NCT06293053 · RECRUITING
Trial details
- NCT number
- NCT06293053
- Sponsor
- Sanofi
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-15
- Primary completion
- 2027-10-28
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.